BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1031 related articles for article (PubMed ID: 17270316)

  • 1. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    Wolff E; Widgren K; Scalia Tomba G; Roth A; Lep T; Andersson S
    PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against chickenpox, shingles and rotavirus-infection].
    Hartwig NG; Rümke HC; Visser HK
    Ned Tijdschr Geneeskd; 2009; 153():A913. PubMed ID: 19900343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella and herpes zoster vaccines: WHO position paper, June 2014.
    Wkly Epidemiol Rec; 2014 Jun; 89(25):265-87. PubMed ID: 24983077
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chickenpox and shingles: one virus, two diseases and current vaccination recommendations in Switzerland].
    Eckert N; Masserey Spicher V
    Ther Umsch; 2016; 73(5):247-52. PubMed ID: 27268447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal varicella vaccine immunization in Japan.
    Yoshikawa T; Kawamura Y; Ohashi M
    Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.